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A stereoselective synthesis of 1-substituted (E)-2-aryl-but-1-
en-3-ynes, including tetrasubstituted alkenes, has been 
developed from aryl-substituted α-allenols by treatment with 
the AcCl/NaOH (aqueous) system. This transformation might 
be explained through an elimination of acetic acid, made up 10 
of a δ-hydrogen and the acetate group in the initially formed 
α-allenic acetate. 
Introduction 
The important medicinal properties of compounds containing the 
1,3-enyne moiety, in addition to the use of functionalized 1,3-15 
enynes as building blocks for the preparation of bioactive 
molecules or organic electronic material is now well 
established.1,2 On the other hand, during the past decades the 
allene group has developed from almost a rarity to an established 
member of the weaponry utilized in modern organic synthetic 20 
chemistry.3 In particular, transformations involving allenols have 
been pursued with renewed interest.4 However, surprisingly, the 
direct preparation of 1,3-enynes from allenolic moieties has not 
been mentioned in the literature; only Lee and Ma have 
independently reported two-step procedures starting from very 25 
activated allenols, namely, 2-(methoxycarbonyl)-2,3-allenols.5 
We now report a direct stereocontrolled access to the (E)-1,3-
enyne moiety from aryl-substituted α-allenols. 
Results and Discussion 
Starting materials for enyne formation, aryl-substituted α-allenols 30 
1, were readily prepared in good yields from the corresponding 
aldehyde via regiocontrolled indium-mediated Barbier-type 
carbonyl–allenylation reaction using our previously described 
methodology.6 Water-based organic reactions have been gaining 
in popularity because of their synthetic advantages (many 35 
reactive functional groups, such as hydroxy, amine, and 
carboxylic functions, do not require the protection-deprotection 
protocol in such reactions, and many water soluble compounds do 
not need to be converted into their derivatives and can be reacted 
directly), as well as unique reactivity and selectivity that are not 40 
often attained under dry conditions.7 In this context, efforts were 
directed towards a direct approach for the stereoselective 
synthesis of functionalized 1,3-enynes 2 by reaction of aryl-
substituted α-allenols 1 in an aqueous medium. Initial 
experiments were carried out using as a model substrate allenol 45 
1a just by the addition of acetyl chloride and aqueous NaOH. We 
observed that the reaction did not proceed “on water”, probably 
because substrate 1a is completely insoluble in aqueous media. 
After some experimentation, it was found that the use of a 
biphasic water/dichloromethane mixture was necessary for the 50 
reaction to occur. When phenyl-substituted allenol 1a was treated 
with acetyl chloride and aqueous NaOH/dichloromethane (1:1) at 
room temperature, the 1,2-diphenyl (E)-1,3-enyne 2a was directly 
formed in 76% after 24 hours (Scheme 1). Thus, allenol 1a 
undergoes an elimination of water, made up of a δ-hydrogen and 55 
the hydroxyl group.8 Having established the optimal reaction 
conditions, we explored the scope of the methodology by 
subjecting a range of aryl-substituted α-allenols 1b– g to 
dehydration/rearrangement and the results are shown in 
Scheme 1. In each case, the crude reaction mixtures are extremely 60 
clean and (E)-1,3-enynes 2b–g are the only products detected 
(Scheme 1).9 Besides, as revealed in Scheme 1, various aryl-
substituted allenols were suitable for such reaction. For example, 
phenyl, p-methoxyphenyl, and p-bromophenyl substituents at the 
allene side were tolerated. Next, we decide to use heteroaromatic 65 
α-allenol derivatives as the reactants. Tolerance toward this type 
of substituents at the alkene end was demonstrated by the 
obtention of the corresponding indole derivative 2g in fair yield.  
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Scheme 1 Direct synthesis of arene-tethered (E)-1,3-enynes 2a–g from 70 
allenols 1a–g. 
 Satisfied with the above results, we set out to evaluate the 
reaction for substrates that contain stereocenters. Thus, a series of 
aliphatic enantiopure α-allenol derivatives were tested (Scheme 
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2). Allenols 1h and 1i were smoothly converted into the desired 
1,3-enynes 2h and 2i. To assess scope, the even more challenging 
enantiopure 2-azetidinone-tethered allenols 1j–l were tested as 
precursors. Similarly, the aliphatic chain bearing a β-lactam 
moiety also afforded the expected (E)-1,3-enynes 2j–l as single 5 
isomers. These results indicate that the stereochemical integrity at 
the heterocyclic estereocenters was retained in the course of the 
reaction. 
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Scheme 2 Direct synthesis of enantiopure (E)-1,3-enynes 2h–l from 10 
allenols 1h–l. 
 Despite Lee’s and Ma’s statement that tetrasubstituted alkenes 
bearing ethynyl groups could not be prepared because acylation 
of the corresponding tertiary allenolic moiety did not work,5 we 
decide to test our method with highly hindered allenols 1m–r. To 15 
our delight, when the allene substituent was moved in the 2-
azetidinone ring from position C4 to C3, as in (3R,4S)-3-
hydroxy-3-(1-phenylpropa-1,2-dienyl)azetidin-2-ones 1m–q, it 
furnished the corresponding enyne β-lactams 2m–q in fair yields 
in its reaction with the AcCl/NaOH (aqueous) system. Whereas 20 
the reaction of allenols 1m, 1n, 1p, and 1q did take place with 
complete stereoselectivity, thus forming adducts (E)-2m, (E)-2n, 
(E)-2p, and (E)-2q, the dehydration/rearrangement of its 
dimethoxyaryl homologue 1o gave 1,3-enynes 2o with absence of 
total stereoselectivity [(E)-2o/(Z)-2o = 78: 22]. Fortunately, the 25 
isomeric 1,3-enynes (E)-2o and (Z)-2o were easily separated by 
column chromatography. Remarkably, Scheme 3 shows how the 
mild conditions of the process allow the stereoselective formation 
of tetrasubstituted enyne β-lactams without harming the sensitive 
four-membered ring. However, when the tether for the 30 
tetrasubstituted enyne formation is a NH-oxindole ring, e.g. 1r, 
the reaction did not give the expected product 2r, instead, an 
unidentified mixture was formed (Scheme 3). 
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Scheme 3 Direct synthesis of tetrasubstituted 1,3-enynes 2m–q from 35 
tertiary allenols 1m–q. 
 A possible reaction course for the dehydration/rearrangement 
process is shown in Scheme 4. Initially, the reaction of allenols 1 
with acetyl chloride affords the non-isolable allenic acetates 3. 
Next, sodium hydroxide abstracts the distal allenic proton of 40 
intermediates 3, which evolve to (E)-1,3-enynes 2 through 
subsequent triple bond generation with concomitant acetate 
elimination. 
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Scheme 4 Proposed mechanism for the direct formation of 1,3-enynes 2 45 
from allenols 1. 
Conclusions 
In conclusion, we have successfully accomplished a very 
attractive strategy for the direct stereoselective synthesis of the 
chemically and biologically relevant 1,3-enyne moiety from 50 
readily available aryl-substituted α-allenols. 
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Experimental section 
1H NMR and 13C NMR spectra were recorded on a Bruker 
Avance AVIII-700 with cryoprobe, Bruker Avance-300, Varian 
VRX-300S or Bruker AC-200. NMR spectra were recorded in 
CDCl3 solutions, except otherwise stated. Chemical shifts are 5 
given in ppm relative to TMS (1H, 0.0 ppm), or CDCl3 (13C, 76.9 
ppm). Low and high resolution mass spectra were taken on an 
AGILENT 6520 Accurate-Mass QTOF LC/MS spectrometer 
using the electronic impact (EI) or electrospray modes (ES) 
unless otherwise stated. Specific rotation [α]D is given in 10–1 deg 10 
cm2 g–1 at 20 °C, and the concentration (c) is expressed in g per 
100 mL. All commercially available compounds were used 
without further purification. 
Indium-promoted reaction between 3-substituted prop-2-ynyl 
bromides and aldehydes; general procedure for the synthesis 15 
of α-allenic alcohols 1a–o. 1-Bromo-3-phenyl-2-propyne, 1-
bromo-3-(p-methoxphenyl)-2-propyne, or 1-bromo-3-(p-
bromophenyl)-2-propyne (3.0 mmol) was added to a well stirred 
suspension of the corresponding aldehyde (1.0 mmol) and indium 
powder (6.0 mmol) in THF/NH4Cl (aq. sat.) (1:5, 5 mL) at 0 oC. 20 
After disappearance of the starting material (TLC) the mixture 
was extracted with ethyl acetate (3 x 5 mL). The organic extract 
was washed with brine, dried (MgSO4) and concentrated under 
reduced pressure. Chromatography of the residue using ethyl 
acetate/hexanes mixtures gave analytically pure compounds. 25 
Spectroscopic and analytical data for previously unreported α-
allenic alcohols 1 follow. 
α-Allenic alcohol 1e. From 250 mg (2.08 mmol) of p-
anisaldehyde, and after chromatography of the residue using 
hexanes/ethyl acetate (6:1) as eluent gave compound 1e (374 mg, 30 
68%) as a colorless oil; 1H NMR (300 MHz, CDCl3, 25 oC): δ = 
7.35 (d, 2H, J = 8.0 Hz), 7.29 (d, 2H, J = 9.0 Hz), 7.15 (d, 2H, J = 
7.9 Hz), 6.81 (d, 2H, J = 8.9 Hz), 5.64 (br s, 1H), 5.34 (dd, 1H, 
JAB = 11.9, 2.6 Hz), 5.29 (dd, 1H, JAB = 11.9, 2.6 Hz), 3.77 (s, 
3H), 2.34 (s, 3H); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 207.2, 35 
158.7, 139.1, 137.5, 133.0, 129.1 (2C), 128.1 (2C), 126.9 (2C), 
113.9 (2C), 109.5, 81.3, 72.3, 55.2, 21.1; IR (CHCl3): ν = 3365, 
2990, 1944 cm–1; HRMS (ES): calcd for C18H18O2 [M
 
]+: 
266.1307; found: 266.1304. 
α-Allenic alcohol 1f. From 290 mg (0.92 mmol) of p-40 
bromobenzaldehyde, and after chromatography of the residue 
using hexanes/ethyl acetate (10:1) as eluent gave compound 1f 
(191 mg, 69%) as a colorless oil; 1H NMR (300 MHz, CDCl3, 25 
oC): δ = 7.40 (d, 2H, J = 8.6 Hz), 7.35 (d, 2H, J = 8.1 Hz), 7.26 
(d, 2H, J = 8.6 Hz), 7.17 (d, 2H, J = 8.0 Hz), 5.64 (t, 1H, J = 2.2 45 
Hz), 5.32 (dd, 1H, JAB = 12.3, 2.5 Hz), 5.26 (dd, 1H, JAB = 12.3, 
2.5 Hz), 2.57 (s, 3H); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 
207.6, 138.6, 137.6, 132.9, 131.4 (2C), 129.1 (2C), 128.5 (2C), 
126.7 (2C), 120.8, 109.0, 81.5, 72.1, 21.1; IR (CHCl3): ν = 3360, 
2992, 1941 cm–1; HRMS (ES): calcd for C17H1579BrO [M
 
]+: 50 
314.0306; found: 314.0303. 
α-Allenic alcohol (–)-1i. From 397 mg (3.05 mmol) of (R)-2,3-
O-isopropylideneglyceraldehyde, and after chromatography of 
the residue using hexanes/ethyl acetate (6:1) as eluent gave 
compound (–)-1i (505 mg, 60%) as a colorless oil; [α]D = −10.0 55 
(c 0.2, CHCl3); 1H NMR (300 MHz, CDCl3, 25 oC): δ = 7.39 (d, 
2H, J = 8.9 Hz), 6.91 (d, 2H, J = 8.9 Hz), 5.30-5.28 (m, 2H), 4.90 
(dd, 1H, J = 6.3, 2.6 Hz), 4.36 (td, 1H, J = 6.6, 3.8 Hz), 4.13 (dd, 
1H, J = 13.7, 7.2 Hz), 4.06 (dd, 1H, J = 12.4, 6.6 Hz), 3.94-3.92 
(m, 1H), 3.84 (s, 3H), 1.51 (s, 3H), 1.39 (s, 3H); 13C NMR (75 60 
MHz, CDCl3, 25 oC): δ = 207.5, 158.9. 133.0, 127.8 (2C), 126.0, 
114.1 (2C), 109.2, 80.9, 77.2, 69.4, 64.5, 55.3, 26.4, 24.9; IR 
(CHCl3): ν = 3362, 2994, 1942 cm–1; HRMS (ES): calcd for 
C16H20O4 [M
 
]+: 276.1362; found: 276.1362. 
α-Allenic alcohol (+)-1j. From 500 mg (2.01 mmol) of the 65 
corresponding β-lactam carbaldehyde, and after chromatography 
of the residue using hexanes/ethyl acetate (4:1) as eluent gave 
compound (+)-1i (431 mg, 59%) as a colorless oil; [α]D = +43.3 
(c 0.4, CHCl3); 1H NMR (300 MHz, CDCl3, 25 oC): δ = 7.46-7.40 
(m, 2H), 7.40-7.35 (m, 2H), 7.33-7.31 (m, 1H), 7.29-7.22 (m, 70 
2H), 7.02-6.95 (m, 3H), 5.22 (d, 1H, J = 5.0 Hz), 5.23-5.18 (m, 
1H), 5.12-5.08 (m, 1H), 5.06 (br s, 1H), 4.18 (dd, 1H, J = 6.6, 5.0 
Hz), 3.36 (dd, 1H, J = 13.7, 8.5 Hz), 3.19 (dd, 1H, J = 13.7, 6.6 
Hz), 2.22 (br s, 1H), 2.07-1.98 (m, 1H), 0.96 (d, 3H, J = 6.7 Hz), 
0.92 (d, 3H, J = 6.6 Hz); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 75 
207.8, 166.6, 157.7, 134.0, 129.4 (2C), 128.8 (2C), 127.5, 126.8 
(2C), 122.4, 116.0 (2C), 107.2, 80.6, 80.3, 69.8, 60.5, 49.6, 27.0, 
20.4, 20.2; IR (CHCl3): ν = 3364, 2991, 1943, 1744 cm–1; HRMS 
(ES): calcd for C23H25NO3 [M
 
]+: 363.1834; found: 363.1839. 
α-Allenic alcohol (+)-1l. From 463 mg (1.64 mmol) of the 80 
corresponding β-lactam carbaldehyde, and after chromatography 
of the residue using hexanes/ethyl acetate (4:1) as eluent gave 
compound (+)-1l (283 mg, 44%) as a colorless oil; [α]D = +14.5 
(c 0.5, CHCl3); 1H NMR (300 MHz, CDCl3, 25 oC): δ = 7.28-7.22 
(m, 9H), 7.18-7.13 (m, 3H), 6.94-6.85 (m, 3H), 5.11 (d, 1H, J = 85 
5.0 Hz), 5.00-4.92 (m, 4H), 4.79 (d, 1H, J = 14.8 Hz), 4.37 (d, 
1H, J = 14.8 Hz); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 207.8, 
166.5, 157.7, 135.9, 133.9, 129.4 (2C), 128.8 (2C), 128.7 (2C), 
128.4 (2C), 127.8, 127.5, 126.7 (2C), 122.3, 116.0 (2C), 106.8, 
80.6, 80.4, 70.2. 59.8, 45.8; IR (CHCl3): ν = 3361, 2988, 1940, 90 
1741 cm–1; HRMS (ES): calcd for C26H23NO3 [M
 
]+: 397.1678; 
found: 397.1675. 
α-Allenic alcohol 1n. From 110 mg (0.29 mmol) of the 
corresponding azetidine-2,3-dione, and after chromatography of 
the residue using hexanes/ethyl acetate (2:1) as eluent gave 95 
compound 1n (67 mg, 63%) as a colorless oil; 1H NMR (300 
MHz, CDCl3, 25 oC): δ = 7.50 (d, 2H, J = 7.1 Hz), 7.36-7.17 (m, 
10H), 6.70 (d, 2H, J = 9.1 Hz), 5.30 (d, 2H, J = 5.3 Hz), 5.24 (s, 
1H), 3.66 (s, 3H); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 208.0, 
164.9, 156.4, 133.5, 132.6, 130.4, 129.1, 129.0 (2C), 128.6 (2C), 100 
128.2 (2C), 128.1 (2C), 127.7, 119.0 (2C), 114.3 (2C), 105.6, 
86.0, 81.2, 67.9, 55.5; IR (CHCl3): ν = 3371, 2998, 1946, 1749 
cm–1; HRMS (ES): calcd for C25H21NO3 [M
 
]+: 383.1521; found: 
383.1530. 
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α-Allenic alcohol 1o. From 215 mg (1.70 mmol) of the 
corresponding azetidine-2,3-dione, and after chromatography of 
the residue using hexanes/ethyl acetate (2:1) as eluent gave 
compound 1o (198 mg, 68%) as a colorless oil; 1H NMR (300 
MHz, CDCl3, 25 oC): δ = 7.41 (d, 2H, J = 7.0 Hz), 7.24-7.15 (m, 5 
6H), 7.03-6.99 (m, 2H), 6.40 (br s, 1H), 6.35 (s, 1H), 6.34 (s, 
1H), 5.20 (d, 1H, JAB = 12.6 Hz), 5.15 (d, 1H, JAB = 12.6 Hz), 
4.84 (d, 1H, J = 15.0 Hz), 4.57 (s, 1H), 3.81 (d, 1H, J = 15.0 Hz), 
3.70 (s, 6H); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 207.5, 
168.3, 161.2, 136.0, 134.9, 132.5, 128.7 (2C), 128.4 (2C), 128.3 10 
(2C), 128.1 (2C), 127.7. 127.5, 106.3 (2C), 105.3, 100.9, 87.2, 
81.0, 77.1, 67.8, 55.4 (2Me), 44.0; IR (CHCl3): ν = 3373, 3000, 
1947, 1750 cm–1; HRMS (ES): calcd for C27H25NO4 [M
 
]+: 
427.1784; found: 427.1792. 
α-Allenic alcohol (+)-1q. From 150 mg (0.52 mmol) of the 15 
corresponding azetidine-2,3-dione, and after chromatography of 
the residue using hexanes/ethyl acetate (3:1) as eluent gave 
compound (+)-1q (153 mg, 60%) as a colorless oil; [α]D = +2.3 
(c 0.2, CHCl3); 1H NMR (300 MHz, CDCl3, 25 oC): δ = 7.57-7.55 
(m, 4H), 7.46 (d, 2H, J = 9.0 Hz), 6.85 (d, 2H, J = 9.0 Hz), 5.31 20 
(s, 2H), 4.63 (s, 1H), 4.55 (dd, 1H, J = 13.7, 6.7 Hz), 4.40 (d, 1H, 
J = 6.7 Hz), 4.30 (d, 1H, J = 8.9, 6.7 Hz), 3.80 (m, 4H), 1.47 (s, 
3H), 1.38 (s, 3H); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 207.9, 
166.2. 156.8, 131.7 (2C), 130.5, 130.0 (2C), 128.3, 121.9, 120.2 
(2C), 114.1 (2C), 109.9, 105.3, 84.2, 81.3, 76.4, 66.8, 66.5, 55.5, 25 
26.5, 25.2; IR (CHCl3): ν = 3381, 3003, 1945, 1752 cm–1; HRMS 
(ES): calcd for C24H2479BrNO5 [M
 
]+: 485.0838; found: 485.0829. 
General Procedure for the Synthesis of (E)-1,3-Enynes 2a–o 
in Aqueous Media. Tetrabutyl ammonium iodide (cat), 50% 
aqueous sodium hydroxide (5 mL) and acetyl chloride (0.22 30 
mmol) were sequentially added at room temperature to a solution 
of the appropriate α-allenol 1 (0.20 mmol) in dichloromethane (4 
mL). The reaction was stirred for 24 h before being partitioned 
between dichloromethane and water. The aqueous phase was 
extracted with dichloromethane (3 x 10 mL). The organic extract 35 
was washed with water and brine, dried (MgSO4) and 
concentrated under reduced pressure. Chromatography of the 
residue using ethyl acetate/hexanes mixtures gave analytically 
pure compounds. Spectroscopic and analytical data for 
compounds 2 follow. 40 
(E)-1,3-Enyne 2a. From 200 mg (0.90 mmol) of α-allenol 1a, 
and after chromatography of the residue using hexanes/ethyl 
acetate (10:1) as eluent gave compound 2a (139 mg, 76%) as a 
colorless oil; 1H NMR (300 MHz, CDCl3, 25 oC): δ = 8.03 (d, 
2H, J = 7.3 Hz), 7.79 (d, 2H, J = 7.0 Hz), 7.48-7.43 (m, 4H), 7.37 45 
(d, 2H, J = 7.3 Hz), 7.29 (s, 1H), 3.59 (d, 1H, J = 0.6 Hz); 13C 
NMR (75 MHz, CDCl3, 25 oC): δ = 139.2, 136.4, 136.2, 129.1 
(2C), 128.6, 128.5 (2C), 128.3 (2C), 128.0, 126.4 (2C), 121.0, 
85.3, 82.4; IR (CHCl3): ν = 3285, 3020, 1600 cm–1; HRMS (ES): 
calcd for C16H12 [M
 
]+: 204.0939; found: 204.0937. 50 
(E)-1,3-Enyne 2b. From 200 mg (0.79 mmol) of α-allenol 1b, 
and after chromatography of the residue using hexanes/ethyl 
acetate (8:1) as eluent gave compound 2b (125 mg, 67%) as a 
colorless oil; 1H NMR (300 MHz, CDCl3, 25 oC): δ = 7.88 (d, 
2H, J = 8.8 Hz), 7.63 (d, 2H, J = 7.1 Hz), 7.33-7.17 (m, 3H), 7.10 55 
(s, 1H), 6.85 (d, 2H, J = 8.8 Hz), 3.76 (s, 3H), 3.46 (s, 1H); 13C 
NMR (75 MHz, CDCl3, 25 oC): δ = 159.8, 139.4, 135.9, 130.6 
(2C), 129.1, 128.6 (2C), 127.6, 126.2 (2C), 118.2, 113.7 (2C), 
84.9, 82.8, 55.3; IR (CHCl3): ν = 3286, 3021, 1599 cm–1; HRMS 
(ES): calcd for C17H14O [M
 
]+: 234.1045; found: 234.1037. 60 
(E)-1,3-Enyne 2c. From 200 mg (0.85 mmol) of α-allenol 1c, 
and after chromatography of the residue using hexanes/ethyl 
acetate (5:1) as eluent gave compound 2c (133 mg, 71%) as a 
colorless oil; 1H NMR (300 MHz, CDCl3, 25 oC): δ = 7.96 (d, 
2H, J = 8.0 Hz), 7.80 (dd, 2H, J = 8.0, 1.3 Hz), 7.48-7.38 (m, 65 
3H), 7.29-7.27 (m, 2H), 7.27 (s, 1H), 3.60 (d, 1H, J = 0.7 Hz), 
2.46 (s, 3H); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 139.3, 
138.7, 136.4, 133.4, 129.1 (2C), 129.0 (2C), 128.4 (2C), 127.8, 
126.3 (2C), 119.6, 85.1, 82.6, 21.4; IR (CHCl3): ν = 3288, 3016, 
1601 cm–1; HRMS (ES): calcd for C17H14 [M
 
]+: 218.1096; found: 70 
234. 218.1087. 
(E)-1,3-Enyne 2d. From 200 mg (0.78 mmol) of α-allenol 1d, 
and after chromatography of the residue using hexanes/ethyl 
acetate (6:1) as eluent gave compound 2d (166 mg, 89%) as a 
colorless oil; 1H NMR (300 MHz, CDCl3, 25 oC): δ = 7.81 (d, 75 
2H, J = 8.5 Hz), 7.62 (dd, 2H, J = 8.5, 1.0 Hz), 7.32-7.24 (m, 
5H), 7.08 (s, 1H), 3.47 (d, 1H, J = 0.6 Hz); 13C NMR (75 MHz, 
CDCl3, 25 oC): δ = 138.8, 134.9, 134.6, 134.1, 130.3 (2C), 128.5 
(4C), 128.2, 126.4 (2C), 121.3, 85.9, 82.1; IR (CHCl3): ν = 3283, 
3019, 1606 cm–1; HRMS (ES): calcd for C16H11Cl [M]+: 80 
238.0549; found: 238.0554. 
(E)-1,3-Enyne 2e. From 315 mg (1.18 mmol) of α-allenol 1e, 
and after chromatography of the residue using hexanes/ethyl 
acetate (6:1) as eluent gave compound 2e (187 mg, 63%) as a 
colorless oil; 1H NMR (300 MHz, CDCl3, 25 oC): δ = 7.93 (d, 85 
2H, J = 8.3 Hz), 7.73 (d, 2H, J = 8.9 Hz), 7.26 (d, 2H, J = 8.3 
Hz); 7.20 (s, 1H), 6.98 (d, 2H, J = 8.9 Hz), 3.89 (s, 3H), 3.58 (d, 
1H, J = 0.7 Hz), 2.44 (s, 3H); 13C NMR (75 MHz, CDCl3, 25 oC): 
δ = 159.4, 138.3, 134.7, 133.6, 131.8, 128.9 (2C), 128.8 (2C), 
127.4 (2C), 119.1, 113.8 (2C), 84.9, 82.7, 55.3, 21.4; IR (CHCl3): 90 
ν = 3284, 3010, 1606 cm–1; HRMS (ES): calcd for C18H16O [M]+: 
248.1201; found: 248.1191. 
(E)-1,3-Enyne 2f. From 290 mg (0.92 mmol) of α-allenol 1f, and 
after chromatography of the residue using hexanes/ethyl acetate 
(10:1) as eluent gave compound 2f (191 mg, 69%) as a colorless 95 
oil; 1H NMR (300 MHz, CDCl3, 25 oC): δ = 7.76 (d, 2H, J = 8.0 
Hz), 7.47 (d, 2H, J = 8.8 Hz), 7.38 (d, 2H, J = 8.8 Hz), 7.09 (d, 
2H, J = 8.0 Hz), 7.07 (s, 1H), 3.42 (d, 1H, J = 0.6 Hz), 2.27 (s, 
3H); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 139.0, 138.2, 136.6, 
133.1, 131.4 (2C), 129.1 (2C), 129.0 (2C), 127.8 (2C), 121.7, 100 
118.4, 85.5, 82.1, 21.4; IR (CHCl3): ν = 3290, 3027, 1598 cm–1; 
HRMS (ES): calcd for C17H1379Br [M]+: 296.0201; found: 
296.0205. 
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(E)-1,3-Enyne 2g. From 50 mg (0.14 mmol) of α-allenol 1g, and 
after chromatography of the residue using hexanes/ethyl acetate 
(4:1) as eluent gave compound 2g (33 mg, 68%) as a colorless 
oil; 1H NMR (300 MHz, CDCl3, 25 oC): δ = 8.09 (d, 1H, J = 8.0 
Hz), 7.65-7.62 (m, 1H), 7.28-7.25 (m, 7H), 7.21 (s, 1H), 6.24 (t, 5 
1H, J = 6.7 Hz); 3.13-2.97 (m, 1H), 1.59 (s, 9H); 13C NMR (75 
MHz, CDCl3, 25 oC): δ = 170.2, 138.1, 131.6 (2C), 128.2 (2C), 
127.9 (2C), 127.8, 126.1, 124.7, 124.1, 123.1, 122.8, 119.8, 
118.7, 115.5, 85.1, 83.0, 28.1, 28.2 (3C); IR (CHCl3): ν = 3281, 
3007, 1707, 1602 cm–1; HRMS (ES): calcd for C23H21NO2 [M
 
]+: 10 
343.1572; found: 343.1580. 
(E)-1,3-Enyne (+)-2h. From 135 mg (0.55 mmol) of α-allenol 
(+)-1h, and after chromatography of the residue using 
hexanes/ethyl acetate (7:1) as eluent gave compound (+)-2h (88 
mg, 69%) as a colorless oil; [α]D = +30.0 (c 0.5, CHCl3); 
1H 15 
NMR (300 MHz, CDCl3, 25 oC): δ = 7.55 (dd, 2H, J = 8.2, 1.6 
Hz), 7.28-7.23 (m, 3H), 6.39 (d, 1H, J = 8.2 Hz), 5.18 (dd, 1H, J 
= 14.5, 7.2 Hz), 4.21 (dd, 1H, J = 8.2, 6.3 Hz), 3.62 (dd, 1H, J = 
8.2, 7.2 Hz), 3.34 (s, 1H), 1.41 (s, 3H), 1.37 (s, 3H); 13C NMR 
(75 MHz, CDCl3, 25 oC): δ = 136.5, 136.4, 128.4 (3C), 126.1 20 
(2C), 125.3, 109.6, 84.8, 19.6, 75.1, 68.9, 26.7, 25.8; IR (CHCl3): 
ν = 3298, 3080, 1610 cm–1; HRMS (ES): calcd for C15H16O2 
[M]+: 228.1150; found: 228.1143. 
(E)-1,3-Enyne (+)-2i. From 120 mg (0.43 mmol) of α-allenol (–
)-1i, and after chromatography of the residue using hexanes/ethyl 25 
acetate (4:1) as eluent gave compound (+)-2i (82 mg, 73%) as a 
colorless oil; [α]D = +18.3 (c 0.6, CHCl3); 
1H NMR (300 MHz, 
CDCl3, 25 oC): δ = 7.57 (d, 2H, J = 9.1 Hz), 6.89 (d, 2H, J = 9.1 
Hz), 6.35 (dd, 1H, J = 8.3, 0.6 Hz), 5.31-5.22 (m, 1H), 4.28 (dd, 
1H, J = 8.3, 6.2 Hz), 3.83 (s, 3H), 3.69 (dd, 1H, J = 8.3, 7.3 Hz), 30 
3.40 (d, 1H, J = 0.6 Hz), 1.49 (s, 3H), 1.45 (s, 3H); 13C NMR (75 
MHz, CDCl3, 25 oC): δ = 159.9, 134.2, 129.0, 127.4 (2C), 124.8, 
113.8 (2C), 109.5, 84.6, 79.8, 75.2, 68.9, 55.3, 26.7, 25.8; IR 
(CHCl3): ν = 3296, 3084, 1611 cm–1; HRMS (ES): calcd for 
C16H18O3 [M]+: 258.1256; found: 258.1251. 35 
(E)-1,3-Enyne (+)-2j. From 155 mg (0.43 mmol) of α-allenol 
(+)-1j, and after chromatography of the residue using 
hexanes/ethyl acetate (3:1) as eluent gave compound (+)-2j (131 
mg, 88%) as a colorless oil; [α]D = +72.7 (c 1.5, CHCl3); 
1H 
NMR (300 MHz, CDCl3, 25 oC): δ = 7.43-7.39 (m, 2H), 7.25-40 
7.22 (m, 3H), 7.18-7.14 (m, 2H), 6.93-6.88 (m, 3H), 6.41 (dd, 
1H, J = 9.6, 0.6 Hz), 5.34 (d, 1H, J = 4.4 Hz), 5.09 (dd, 1H, J = 
9.6, 4.4 Hz), 3.40 (d, 1H, J = 0.6 Hz), 3.14 (dd, 1H, J = 13.9, 7.7 
Hz), 2.85 (dd, 1H, J = 13.9, 6.7 Hz), 1.97-1.85 (m, 1H), 0.89 (t, 
6H, J = 6.7 Hz); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 165.7, 45 
157.3, 136.4, 131.3, 129.5 (2C), 129.4, 128.9, 128.5 (2C), 126.3 
(2C), 122.3, 115.5 (2C), 85.0, 81.9, 79.8, 59.2, 48.7, 27.5. 20.4 
(2C); IR (CHCl3): ν = 3290, 3033, 1734, 1606 cm–1; HRMS (ES): 
calcd for C23H23NO2 [M]+: 345.1729; found: 345.1735. 
(E)-1,3-Enyne (+)-2k. From 91 mg (0.26 mmol) of α-allenol (+)-50 
1k, and after chromatography of the residue using hexanes/ethyl 
acetate (3:1) as eluent gave compound (+)-2k (55 mg, 63%) as a 
colorless oil; [α]D = +23.3 (c 1.5, CHCl3); 
1H NMR (300 MHz, 
CDCl3, 25 oC): δ = 7.59 (dd, 2H, J = 8.0, 1.9 Hz), 7.34 (d, 2H, J 
= 9.0 Hz), 7.30-7.26 (m, 3H), 6.78 (d, 2H, J = 9.0 Hz), 6.54 (d, 55 
1H, J = 9.6 Hz), 5.31 (dd, 1H, J = 9.6, 4.8 Hz), 4.74 (d, 1H, J = 
4.8 Hz), 3.69 (s, 3H), 3.54 (s, 1H), 3.45 (s, 3H); 13C NMR (75 
MHz, CDCl3, 25 oC): δ = 163.3, 156.5, 147.0, 136.1, 132.3, 
131.0, 128.9, 128.8 (2C), 126.3 (2C), 118.5 (2C), 114.5 (2C), 
86.0, 85.0, 75.9, 59.0, 58.5, 55.5; IR (CHCl3): ν = 3292, 3030, 60 
1731, 1603 cm–1; HRMS (ES): calcd for C21H19NO3 [M]+: 
333.1365; found: 333.1371. 
(E)-1,3-Enyne (+)-2l. From 75 mg (0.19 mmol) of α-allenol (+)-
1l, and after chromatography of the residue using hexanes/ethyl 
acetate (3:1) as eluent gave compound (+)-2l (61 mg, 84%) as a 65 
colorless oil; [α]D = +50.0 (c 1.9, CHCl3); 
1H NMR (300 MHz, 
CDCl3, 25 oC): δ = 7.26-7.13 (m, 12H), 6.89-6.86 (m, 3H), 6.26 
(dd, 1H, J = 9.8, 0.6 Hz), 5.30 (d, 1H, J = 4.4 Hz), 5.00 (dd, 1H, J 
= 9.8, 4.4 Hz), 4.53 (d, 1H, J = 14.7 Hz), 4.16 (d, 1H, J = 14.7 
Hz), 3.26 (d, 1H, J = 0.6 Hz); 13C NMR (75 MHz, CDCl3, 25 oC): 70 
δ = 164.9, 157.2, 136.3, 135.3, 131.0 (2C), 129.5 (2C), 129.2, 
128.8 (4C), 128.4 (2C), 127.9 (2C), 126.2, 122.2, 115.4 (2C), 
85.1, 82.1, 79.6, 58.3, 45.0; IR (CHCl3): ν = 3288, 303q, 1735, 
1605 cm–1; HRMS (ES): calcd for C26H21NO2 [M]+: 379.1572; 
found: 379.1578. 75 
(E)-1,3-Enyne (–)-2m. From 105 mg (0.26 mmol) of α-allenol 
(+)-1m, and after chromatography of the residue using 
hexanes/ethyl acetate (2:1) as eluent gave compound (–)-2m (85 
mg, 84%) as a colorless oil; [α]D = –126.9 (c 2.6, CHCl3); 
1H 
NMR (300 MHz, CDCl3, 25 oC): δ = 8.08 (dd, 2H, J = 8.0, 1.9 80 
Hz), 7.57 (d, 2H, J = 9.1 Hz), 7.44-7.41 (m, 3H), 6.90 (d, 2H, J = 
9.1 Hz); 4.82 (d, 1H, J = 5.6 Hz), 4.60 (dd, 1H, J = 12.6, 6.7 Hz), 
4.21 (d, 2H, J = 6.7 Hz), 3.81 (s, 3H), 3.51 (s, 1H), 1.44 (s, 3H), 
1.35 (s, 3H); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 158.5, 
156.6, 142.1, 133.3, 131.2, 129.9, 129.2 (2C), 128.2 (2C), 123.1, 85 
120.0 (2C), 114.1 (2C), 109.7, 85.5, 80.8, 77.2, 67.0, 61.8, 55.4, 
26.4, 25.5; IR (CHCl3): ν = 3285, 3044, 1726, 1598 cm–1; HRMS 
(ES): calcd for C24H23NO4 [M]+: 389.1627; found: 389.1629. 
(E)-1,3-Enyne 2n. From 110 mg (0.29 mmol) of α-allenol 1n, 
and after chromatography of the residue using hexanes/ethyl 90 
acetate (2:1) as eluent gave compound 2n (67 mg, 63%) as a 
colorless oil; 1H NMR (300 MHz, CDCl3, 25 oC): δ = 8.09 (dd, 
2H, J = 8.4, 1.6 Hz), 7.43-7.40 (m, 2H), 7.33-7.23 (m, 8H), 6.71 
(d, 2H, J = 9.1 Hz), 5.38 (s, 1H), 3.64 (s, 3H), 3.13 (s, 1H); 13C 
NMR (75 MHz, CDCl3, 25 oC): δ = 158.8, 156.8, 147.0, 136.2, 95 
133.8, 131.4, 130.3, 129.3 (2C), 129.2, 129.1 (2C), 128.8 (2C), 
128.5 (2C), 123.5, 118.9 (2C), 114.9 (2C), 86.3, 79.7, 63.7, 55.8; 
IR (CHCl3): ν = 3284, 3064, 1728, 1596 cm–1; HRMS (ES): calcd 
for C25H19NO2 [M]+: 365.1416; found: 365.1412. 
Reaction of allenol 1o. Preparation of (E)-1,3-enyne 2o and 100 
(Z)-1,3-enyne 2o. From 65 mg (0.15 mmol) of α-allenol 1o and 
after chromatography of the residue using hexanes/ethyl acetate 
(5:1) as eluent, 38 mg (62%) of the less polar compound (E)-2o 
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and 11 mg (18%) of the more polar compound (Z)-2o were 
obtained. 
(E)-1,3-Enyne 2o. Colorless oil; 1H NMR (300 MHz, CDCl3, 25 
oC): δ = 8.09 (dd, 2H, J = 8.2, 1.6 Hz), 7.33-7.11 (m, 8H), 6.40-
6.36 (m, 3H), 4.83 (d, 1H, J = 15.1 Hz), 4.79 (s, 1H), 3.88 (d, 1H, 5 
J = 15.1 Hz), 3.69 (s, 6H), 3.04 (s, 1H); 13C NMR (75 MHz, 
CDCl3, 25 oC): δ = 161.5, 160.9, 147.4, 138.0, 135.3, 133.3, 
129.7, 128.8 (2C), 128.7 (2C), 128.6 (2C), 128.3 (2C), 127.8, 
122.5, 106.3 (2C), 100.6, 85.1, 79.2, 77.1, 62.3, 55.4 (2C), 44.5; 
IR (CHCl3): ν = 3282, 3066, 1726, 1595 cm–1; HRMS (ES): calcd 10 
for C27H23NO3 [M]+: 409.1678; found: 365. 409.1697. 
(Z)-1,3-Enyne 2o. Colorless oil; 1H NMR (300 MHz, CDCl3, 25 
oC): δ = 7.31 (dd, 2H, J = 7.4, 1.9 Hz), 7.25-7.19 (m, 4H), 7.15-
7.11 (m, 4H), 6.27-6.24 (m, 3H), 4.97 (s, 1H), 4.86 (d, 1H, J = 
15.1 Hz), 3.78 (d, 1H, J = 15.1 Hz), 3.62 (s, 6H), 3.51 (s, 1H); 13C 15 
NMR (75 MHz, CDCl3, 25 oC): δ = 162.8, 161.1, 147.3, 137.5, 
135.4, 133.8, 129.3, 128.8 (2C), 128.6 (2C), 128.2 (2C), 128.1 
(2C), 127.9, 127.8, 118.9, 105.8 (2C), 101.1, 85.2, 79.2, 63.7, 
55.4 (2C), 44.4; IR (CHCl3): ν = 3283, 3060, 1726, 1597 cm–1; 
HRMS (ES): calcd for C27H23NO3 [M]+: 409.1678; found: 20 
409.1683. 
(E)-1,3-Enyne (–)-2p. From 390 mg (1.03 mmol) of α-allenol 
(+)-1p, and after chromatography of the residue using 
hexanes/ethyl acetate (2:1) as eluent gave compound (–)-2p (252 
mg, 65%) as a colorless oil; [α]D = –16.0 (c 0.3, CHCl3); 
1H 25 
NMR (300 MHz, CDCl3, 25 oC): δ = 8.15 (d, 1H, J = 8.2 Hz), 
8.14 (d, 1H, J = 7.8 Hz), 7.46-7.34 (m, 8H), 5.10 (d, 1H, J = 14.9 
Hz), 4.54 (dd, 1H, J = 12.5, 6.0 Hz), 4.40 (d, 1H, J = 14.9 Hz), 
4.23 (dd, 1H, J = 8.9, 6.6 Hz), 4.10 (d, 1H, J = 6.0 Hz), 4.00 (dd, 
1H, J = 8.9, 6.0 Hz), 3.39 (s, 1H), 1.50 (s, 3H), 1.41 (s, 3H); 13C 30 
NMR (75 MHz, CDCl3, 25 oC): δ = 161.4, 143.8, 135.9, 133.3, 
129.8, 129.1 (2C), 128.8 (2C), 128.6 (2C), 128.4, 128.3 (2C), 
127.8, 122.2, 109.7, 84.5, 80.5, 67.3, 61.0, 45.7, 26.5, 25.3; IR 
(CHCl3): ν = 3280, 3039, 1723, 1595 cm–1; HRMS (ES): calcd 
for C24H23NO3 [M]+: 373.1678; found: 373.1677. 35 
(E)-1,3-Enyne (–)-2q. From 145 mg (0.30 mmol) of α-allenol 
(+)-1q, and after chromatography of the residue using 
hexanes/ethyl acetate (2:1) as eluent gave compound (–)-2q (77 
mg, 55%) as a colorless oil; [α]D = –2.4 (c 0.1, CHCl3); 
1H NMR 
(300 MHz, CDCl3, 25 oC): δ = 8.00 (d, 2H, J = 8.8 Hz), 7.58 (d, 40 
2H, J = 8.8 Hz), 7.57 (d, 2H, J = 9.0 Hz), 6.93 (d, 2H, J = 9.0 
Hz), 4.83 (d, 1H, J = 5.3 Hz), 4.66-4.59 (m, 1H), 4.22 (d, 1H, J = 
6.3 Hz), 4.21 (d, 1H, J = 7.1 Hz), 3.84 (s, 3H), 3.55 (s, 1H), 1.45 
(s, 3H), 1.37 (s, 3H); 13C NMR (75 MHz, CDCl3, 25 oC): δ = 
158.4, 156.8, 142.6, 132.3, 131.4 (2C), 131.1, 130.8 (2C), 124.5, 45 
121.9, 119.8 (2C), 114.2 (2C), 109.8, 85.9, 80.3, 76.9, 66.9, 61.9, 
55.5, 26.4, 25.5; IR (CHCl3): ν = 3280, 3046, 1726, 1597 cm–1; 
HRMS (ES): calcd for C24H2279BrNO4 [M]+: 467.0732; found: 
467.0751. 
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